From: Evaluation of adult dTPaP vaccination coverage in France: experience in Lyon city, 2010–2011
General recommendations | Vaccines | 18-23 years | 24 years | 26-28 years | 30-45 years | 46-64 years | ≥65 years |
---|---|---|---|---|---|---|---|
Diphtheria (d) Tetanus (T) Poliomyelitis (IPV) | dT-IPV to be replaced by a single dose of dTaP-IPV for adults who have not received pertussis vaccination since 10 years | 1 dose of dT-IPV every 10 years | |||||
Acellular pertussis (aP) | |||||||
Catch-up program | Acellular pertussis (aP) | Replaced by a single dose of dTaP-IPV for adults who have not previously received pertussis vaccination | |||||
Specific and at-risk populations | Acellular pertussis (aP) | A single dose of dTaP-IPV in adults with the prospect of becoming parents (cocoon), family members during pregnancy and post-partum women (minimum interval of 2 years between 1 dose of dT-IPV and dTaP-IPV |